OUR UNDERSTANDING of platelet immunogenicity has closely paralleled the study of
platelet membrane glycoproteins (GPs) and their pivotal role as receptors that mediate the …

Human platelet antibody (HPA) detection is necessary for the diagnosis and therapeutic
decisions for refractoriness to platelet transfusions, post transfusion purpura and fetal and …

BACKGROUND: Neonatal alloimmune thrombocytopenia (NATP) caused by fetomaternal
mismatch for human platelet (PLT) alloantigens (HPAs) complicates approximately 1 in 1000 …

We measured reticulated platelets (RPs) and plasma glycocalicin (GC) and thrombopoietin
(TPO) levels simultaneously in 107 thrombocytopenic patients to clarify the diagnostic value …

Patients with multirefractory immune thrombocytopenia (ITP) have limited treatment options.
Recent data suggest that specific anti-platelet antibodies may cause destruction of platelets …

Now in its Third Edition, this authoritative text continues to provide a comprehensive and
systematic review of the biology, pathobiology, and clinical disorders of the hemostatic …

Thrombocytopenia developing in the course of chemotherapy for malignant disease is
usually attributed to drug‐induced marrow suppression and/or marrow replacement by …

BACKGROUND: Platelet CD36 (glycoprotein [GP] IV) deficiency occurs in 3 to 5 percent of
persons of Asian or African ancestry. A subset of these individuals is at risk for immunization …

BACKGROUND: The technique of allele‐specific polymerase chain reaction (PCR)
amplification has been adapted for DNA‐based human platelet alloantigen typing. STUDY …

OBJECTIVE: The purpose of the study was to attempt to distinguish pregnant women with
gestational thrombocytopenia from those with idiopathic immune thrombocytopenia by eight …